Sharon Shacham
2015
In 2015, Sharon Shacham earned a total compensation of $4.4M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 728% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $103,000 |
|---|---|
| Option Awards | $3,896,500 |
| Salary | $412,000 |
| Other | $10,980 |
| Total | $4,422,480 |
Shacham received $3.9M in option awards, accounting for 88% of the total pay in 2015.
Shacham also received $103K in non-equity incentive plan, $412K in salary and $11K in other compensation.
Rankings
In 2015, Sharon Shacham's compensation ranked 1,905th out of 13,638 executives tracked by ExecPay. In other words, Shacham earned more than 86.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,905 out of 13,638 | 86th |
Division Manufacturing | 687 out of 5,190 | 87th |
Major group Chemicals And Allied Products | 249 out of 1,854 | 87th |
Industry group Drugs | 194 out of 1,528 | 87th |
Industry Pharmaceutical Preparations | 157 out of 1,182 | 87th |
Source: SEC filing on April 28, 2017.
Shacham's colleagues
We found three more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2015.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019